GCP
FLXN

GSA Capital Partners’s Flexion Therapeutics, Inc. FLXN Stock Holding History

GSA Capital Partners’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-55,504
Closed -$497K – 1727
2021
Q1 		$497K Buy
+55,504
New +$636K 0.08% 356
2020
Q2 		– Sell
-24,603
Closed -$194K – 1290
2020
Q1 		$194K Buy
+24,603
New +$371K 0.05% 767
2019
Q4 		– Sell
-18,951
Closed -$260K – 1847
2019
Q3 		$260K Buy
18,951
+477
+3% +$5.66K 0.04% 1031
2019
Q2 		$227K Buy
18,474
+7,334
+66% +$84.6K 0.03% 1174
2019
Q1 		$139K Buy
+11,140
New +$149K 0.01% 1295
2018
Q1 		– Sell
-68,900
Closed -$1.73M – 1903
2017
Q4 		$1.73M Buy
68,900
+32,800
+91% +$803K 0.11% 298
2017
Q3 		$873K Sell
36,100
-25,400
-41% -$597K 0.06% 608
2017
Q2 		$1.24M Buy
+61,500
New +$1.28M 0.08% 396

Other funds holding FLXN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Clearline Capital New York $1.29B AUM 38.13% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return